Skip to main content

Table 2 Distribution of anthropometric, smoking and disease status, specified by steatohepatitis, fatty liver and normal control groups

From: Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study

  Steatohepatitis N = 124 Fatty liver only N = 124 Normal N = 124 P value
n (%) n (%) n (%)  
Sex (women) 20 (5.4) 20 (5.4) 20 (5.4) 1.000
Smoking status (yes) 54 (14.5) 37 (10.0) 44 (11.8) 0.078
Hypertension (>=140/90 mmHg or medication) 45 (12.1) 32 (8.6) 22 (5.9) 0.004
Diabetes mellitus (fasting glucose> = 126 23 (6.2) 11 (3.0) 4 (1.1) 0.000
mg/dL or medication)        
Obesity (BMI> = 27) 66 (17.7) 39 (10.5) 10 (2.7) <.0001
High blood pressure (SBP> = 130 or 61 (16.4) 30 (8.1) 29 (7.8) <.0001
DBP> = 85 mmHg)        
Triglyceride 150 mg/dL 77 (20.7) 60 (16.1) 20 (5.4) <.0001
HDL 40 (men) or 50 mg/dL (women) 46 (12.4) 33 (8.9) 22 (5.9) 0.003
Fasting glucose 110 (mg/dL) 40 (10.8) 20 (5.4) 7 (1.9) <.0001
Metabolic syndrome (Yes) 59 (15.9) 17 (4.6) 6 (1.6) <.0001